28 May, 2026
GXP Consulting strengthens its strategic consulting capabilities with the arrival of Paolo TAMAGNI.
Over the past years, the Life Sciences industry has been evolving rapidly. Companies are operating in an environment shaped by increasing regulatory expectations, accelerating time-to-market pressures, and growing complexity driven by digital transformation and data integrity requirements.
In this context, the role of consulting is also evolving.
Beyond providing high-quality expertise, organisations increasingly require support on complex, high-impact programs, including:
- GMP readiness and remediation initiatives
- Quality system transformation
- Industrial scale-up and process robustness
- Bridging digital ambition with operational execution
GXP Consulting has been supporting clients on these topics for several years, building on strong expertise across GxP environments and trusted relationships within the Life Sciences ecosystem.
The arrival of Paolo reinforces this capability.
Paolo brings over 10 years of experience across the full product lifecycle, from formulation and process engineering to manufacturing scale-up and commercialisation. He has led transformation programs and supported senior leaders in pharmaceutical, biopharmaceutical and medtech organisations on critical challenges such as recurring quality issues, validation complexity, and operational performance.
His background combines technical depth with a strong understanding of business and organisational dynamics, a key asset to support clients in addressing their most demanding challenges.
This addition reflects GXP Consulting’s ongoing commitment to supporting its clients not only with expertise, but also with the experience and perspective required to successfully navigate complex transformations.
